Riyadh – Harmony
The Saudi Food and Drug Authority has issued a newsletter for every health authority to use the 17DJ55 of AZIMAC 250mg, a film-covered tablet, produced by Riyadh Pharma Medical and Cosmetic Products Co. Ltd due to the A different concentration of packaging on the external package. 250 mg "of what is mentioned on the" 500 mg "internal strip, which can lead to double doses.
The Authority noted that there was a report on the difference in the concentration on the AZIMAC external package of 250 mg of the in-house tape of the product, and checking the existence of an imbalance, and directed the manufacturer to withdraw the wrong operation in a hurry, as well as to publish Newsletter for every health authority to give it up If it's available.
The brand name of the product is AZIMAC 500 mg, a film-covered tablet and the scientific name AZITHROMYCIN, and the date of validity of 08/2020, stating that the inspectors have taken advantage of more than 55600 bottles of the product That's a drug store & company in Riyadh.
The FDA advised consumers to check that the concentration on the package is consistent with what is indicated on the tape of the in-house product, to give the best to see and see a doctor.